{
  "id": 15805071,
  "title": "Olfactory neuroepithelium biomarker platform: a proof from Alzheimer's disease",
  "url": "https://urgent.news/2026/10/20/olfactory-neuroepithelium-biomarker-platform-a-proof-from-alzheimers",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-20T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.10.18.759991v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Unlike other diseases where target organs for biopsy are accessible, surrogate platforms are warranted for biomarkers of neuropsychiatric disorders due to the inaccessibility of the brain. We demonstrate a non-invasive platform combining a nasal soft-brush swab with single-cell Western blotting for neuron-specific protein analysis. Applied to Alzheimer's disease targeting phosphorylated tau, this…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Medical Xpress",
        "title": "Lab-designed molecule reduces amyloid beta, the protein linked to Alzheimer's disease, in mice",
        "url": "https://urgent.news/2026/10/17/lab-designed-molecule-reduces-amyloid-beta-the-protein-linked-to",
        "published": "2026-10-17T14:40:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}